Jennifer specializes in Medicare Advantage and Part D and pharmaceutical consulting.
She has assisted clients and certified their Medicare Part C and D bid submissions. She also assists with Employer Group Waiver Plan (EGWP) pricing, Medicare and Fully-Integrated Dual Advantage (FIDA) feasibility studies, CMS one-third financial and bid audits, and Part D settlement estimates.
Jennifer also works with pharmaceutical manufacturer clients related to risk sharing arrangements, market access and profitability analyses through financial forecasting, and helping clients understand the impact of regulatory changes in the pharmacy industry.
She is also well versed in performing financial projections, including risk-based capital and targeted surplus, pricing and reserving for insurers and employers, and premium development for employee benefits.
Prior to joining Milliman, Jennifer worked at a large Blue Cross Blue Shield plan. She was responsible for reserve calculations and forecasting for senior and dental products, trend and disease management, hospital provider financial management, and commercial pharmacy rate development, along with development of Part D bids.
